A Hands-on Approach to Improving Type 2 Diabetes Care: Overcoming Barriers to Optimal Use of Injectables

A Hands-on Approach to Improving Type 2 Diabetes Care: Overcoming Barriers to Optimal Use of Injectables

National Meeting

Tuesday, September 24, 2013

6:30 pm PT - 9:45 pm PT

Preregistration for this symposium is now closed. Onsite registration will be available on a limited first-come, first-served basis.

San Diego Marriott Marquis & Marina
San Diego Ballroom AB
333 West Harbor Drive
San Diego, California


Daniel Einhorn, MD
Clinical Professor of Medicine
University of California San Diego
Medical Director
The Scripps Whittier Diabetes Institute
La Jolla, California

Edward Shahady, MD
Clinical Professor of Family Medicine
University of Miami and University of Florida
Medical Director Diabetes Master Clinician Program FAFP/F
Fernandina Beach, Florida

Dace Trence, MD, FACE
Professor of Medicine
University of Washington
Director, Diabetes Care Center
Seattle, Washington

Intended Learners

This activity is designed for family practice physicians, nurse practitioners, physician assistants, nurses, and other healthcare professionals who care for patients with diabetes.

Learning Objectives

After completing this activity, participants should be able to:

  • Individualize care for patients with type 2 diabetes as suggested by the ADA/EASD position statement
  • Incorporate appropriate strategies for timely initiation, selection, titration, and self-management of insulin in patients with type 2 diabetes
  • Discuss the role and value of GLP-1 receptor agonists in combination with basal insulin
  • Analyze the technological advances associated with available glucose meters and disposable insulin pen devices and their value in the management of patients with type 2 diabetes
  • Describe the importance of glucose meter downloads and be able to identify and interpret patterns and make recommendations to improved diabetes outcomes
Activity Overview

This satellite symposium will occur in the San Diego Ballroom AB of the San Diego Marriott Marquis & Marina on Tuesday, September 24, from 6:30 pm – 9:45 pm. A faculty question-and-answer session will follow the presentations.

To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. Participants who submit a completed evaluation will receive documentation of credit within 8 weeks.

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.


This activity has been planned and implemented by North American Center for Continuing Medical Education, LLC (NACCME) and Horizon CME for the advancement of patient care.  NACCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


NACCME designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.


This continuing nursing education activity awards 2.25 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 2.25 contact hours.

Nurse practitioners participating in this educational activity will earn an AMA PRA Category 1 CreditTM certificate of completion or ANCC contact hours through AANP’s reciprocity agreements.


This live activity, A Hands-On Approach to Improving Type 2 Diabetes Care: Overcoming Barriers to Optimal Use of Injectables, with a beginning date of September 24, 2013, has been reviewed and is acceptable for up to 2.25 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurse planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Planning Committee

The planning committee comprises Janice Baker, MBA, RD, CDE, CNSL, BC-ADM, Andrea M. Gasper, MS, PA-C, Daniel Einhorn, MD, Susie Seaman, NP, Christopher E. Sadler, MA, PA-C, CDE, Edward Shahady, MD, Dace Trence, MD, FACP; Brian Lee, PharmD, Elizabeth Wilkerson, Horizon CME; Mike Kearney, Edward Jackson, MD, Randy Robbin, Lynn Rubin, and Jessica Steuerman, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Ms. Baker: Educator—Bristol-Myers Squibb, Merck
Dr. Einhorn: Stockholder—AstraZeneca, Bristol-Myers Squibb, Halozyme (and spouse), Janssen, Lilly, MannKind (and spouse), Novo Nordisk, Sanofi; Consultant—AstraZeneca, Bristol-Myers Squibb, Halozyme (and spouse), Janssen, Lilly, MannKind (and spouse), Novo Nordisk, Takeda, Sanofi; Clinical trial—AstraZeneca, Bristol-Myers Squibb, Janssen, Lilly, Novo Nordisk, Takeda, Sanofi
Ms. Gasper: Certified pump trainer—Animas, Insulet OmniPod, Johnson & Johnson, Tandum Diabetes care; Consultant—Abbott, Lifescan
Mr. Sadler: Consultant—Boehringer Ingelheim, Lilly, Sanofi; Speaker—Bristol-Myers Squibb, Novo Nordisk, Sanofi, Takeda, Valeritas
Dr. Shahady: Advisory board—Janssen, Lilly, Novo Nordisk, Sanofi; Consultant—Merck; Speaker—Merck
Ms. Seaman: Promotional speakers bureau—Healthpoint Biotherapeutics; Scientific advisor—Healthpoint Biotherapeutics, Molnlycke Health Care
Dr. Trence: Stockholder—Medtronic, sanofi-aventis; Grant support—Lilly

Dr. Jackson, Mr. Robbin, Ms. Rubin, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.

Mr. Kearney: Stock Shareholder—Savient Pharmaceuticals, Inc.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed that the following uses of off-label/unapproved uses of drugs and/or devices will be discussed in the presentations: Investigational use of lixisenatide, U-500 insulin, albiglutide for the treatment of type 2 diabetes.

Product images are used in this presentation for participant clarification purposes only. No product promotion should be inferred.


North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2013 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

This activity was supported by an independent educational grant from Sanofi US.

This event is not part of the official AAFP Scientific Assembly.